drugset / Trial / NCT00548821

Randomized Trial Between Weekly and 5 Day 3 Weekly Cisplatin for Cervical Cancer

NCT00548821 ↗

RandomizedSingle-groupOpen-labelTreatment

Summary

The primary aim of this research protocol is to compare if there is a difference in progression free survival between weekly versus 5-day 3 weekly cisplatin based chemotherapy regimen in women with locally advanced cervical cancer. The secondary aims are to compare quality of life assessment of patients and their carers as well as toxicity profiles both acute and late.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 20 mg/m2 —
Subject Cisplatin Other / unclassified 40 mg/m2 —

Indications